Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

ASCO 2021

Adding Venclexta to Revlimid and Rituxan Leads to Undetectable Cancer in Mantle-Cell Lymphoma

Hot Topics from the 2021 American Society of Clinical Oncology Conference

Racial Disparities in Biomarker Testing Affects Outcomes of Patients with Lung Cancer

Lumakras First Therapy Targeting KRAS Mutation in Patients with Non–Small-Cell Lung Cancer

Tecartus, a CAR T-Cell Therapy, Leads to Complete Remissions in Patients with Acute Lymphoblastic Leukemia

Immunotherapy After Surgery May Be a New Standard of Care for Patients with Advanced Kidney Cancer

Balstilimab a Promising New Immunotherapy for Patients with Advanced Cervical Cancer, Regardless of PD-1/PD-L1 Expression

Lynparza, a PARP Inhibitor, Extends Disease-Free Survival in Patients with Early-Stage Breast Cancer and BRCA Mutation

Using Imfinzi Before Chemotherapy Improves Outcomes in Patients with Early-Stage Triple-Negative Breast Cancer

Immunotherapy Combination plus Radiation a Potential Alternative to Radical Surgery in Patients with Localized Muscle-Invasive Bladder Cancer

Page 2 of 2